Latest News and Press Releases
Want to stay updated on the latest news?
-
REDWOOD CITY, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will discuss the...
-
REDWOOD CITY, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a series...
-
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a...
-
Revenues grow 64.8% over the immediately preceding quarter and a 115.3% increase over the corresponding period of the prior yearLoss per share of 8.5 cents in line with levels of immediately preceding...
-
REDWOOD CITY, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today introduced Biocare Telemed, a virtual...
-
REDWOOD CITY, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has received a 510(k)...
-
REDWOOD CITY, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company announced a strategic partnership with Verizon...
-
REDWOOD CITY, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to announce that it recently...
-
REDWOOD CITY, Calif., April 23, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced that its CEO, Waqaas Al-Siddiq, was...
-
REDWOOD CITY, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it is finalizing its FDA...